Other Products

Nova Eye – iTRACK™

Schwind –  MS39

VisionCare- CentraSight

Tracey Technologies – iTrace

Systems supplied by Medilase are designed to analyse, diagnose and treat vision defects, corneal diseases, retinal disorders which leads to better patient outcomes to significantly improve vision and quality of life for individuals. 

We agree with Tracey Technologies: “Quality of Vision IS Quality of Life”.     

With a legacy that spans more than 30 years in ophthalmology, Nova Eye Medical develops, manufactures and markets a portfolio of proprietary glaucoma treatment technologies designed to advance clinical outcomes and improve patient quality of life.

These technologies include iTrackTM minimally invasive glaucoma surgery (MIGS).

iTrackTM manufactured by Nova Eye Medical is a canal based MIGS procedure, also known as ab-interno canaloplasty. iTrackTM the world’s only device indicated for viscodilation in the treatment of open-angle glaucoma, is helping to redefine the treatment of glaucoma in its early stages. iTrackTM can also be performed via an ab-externo approach to offer a highly effective, bleb-free alternative to traditional glaucoma surgery in the treatment of advanced glaucoma patients.


iTrackTM canaloplasty microcatheter enables you to customize the degree of viscodilation on an individual patient basis, maximizing patient outcomes. iTrackTM is restorative approach to glaucoma.


With the iTrackTM surgical system you can restore the eye’s natural outflow pathway to reduce intraocular pressure (IOP) and eliminate or reduce the medication burden.


Treatment options:

ABICTM – Ab Interno Canaloplasty



SCHWIND eye-tech-solutions is one of the technology leaders for eye lasers for refractive and therapeutic corneal surgery. They develop, produce and market a comprehensive product portfolio for the treatment of vision defects and corneal diseases.

This includes the innovative AMARIS excimer laser systems, diagnostic systems, and treatment planning tools for a uniquely wide scope of applications. CSO MS39 is supplied as a diagnostic analysing tool for treatment planning on the Amaris excimer laser.

MS-39 – supplied by Schwind Eye-tech-solutions – is the most advanced device for the analysis of the anterior segment of the eye. MS-39 combines Placido disk corneal topography, with high resolution OCT-based anterior segment tomography. The clarity of the cross-sectional images, with a 16 mm diameter, along with the many details of the cornea structure and layers revealed by the MS-39, will be appreciated by anterior segment specialists. MS-39 provides information on pachymetry, elevation, curvature and dioptric power of both corneal surfaces.


In addition to anterior segment clinical diagnostics, MS-39 can be used in corneal surgery for refractive surgery planning. An IOL calculation module is also available, based on Ray-Tracing techniques, Additional tools allow MS-39 to perform accurate pupil diameter measurements and the advanced analysis of tear film.

VisionCareTM Ophthalmic Technologies is a developer of advanced visual prosthetic devices designed to significantly improve vision and quality of life for individuals with untreatable retinal disorders.  The Implantable Miniature Telescope – the first FDA-approved implantable medical device demonstrated to improve vision and quality of life in individuals with the most advanced, irreversible form of age-related macular degeneration – is integral to the CentraSight® treatment program which has been developed to help patients follow the necessary steps for proper diagnosis, surgical evaluation, and postoperative care. The goal of Vision Care is to help patients reconnect to the things in life they love to see and do.

The CentraSight® treatment program uses a tiny telescope that is implanted inside the eye to improve vision and quality of life for individuals affected by End-Stage Age-Related Macular Degeneration (AMD). End-Stage AMD is the most advanced form of age-related macular degeneration.

The CentraSight® treatment program involves four steps:

1) diagnosis, 2) candidate evaluation, 3) implantation and 4) rehabilitation.


CentraSight® treatment program does not represent a cure for End-Stage AMD.

CentraSight® treatment program uses a tiny telescope that is implanted inside the eye to improve vision and quality of life for patients with the most advanced form of macular degeneration: end-stage AMD.

Once implanted inside the eye, it magnifies images onto the healthy areas of the light-sensing retina to help improve central (straight ahead) vision.

  • FDA-Approved Implantable Miniature Telescope
  • End-stage AMD treatment

Tracey Technologies beliefs that “Quality of Vision IS Quality of Life”. They are devoted to bringing doctors the technology they need to understand vision at a deeper level.

Analysing vision at the corneal and lenticular level leads to better patient outcomes as iTraceTM doctors are able to more accurately diagnose and precisely treat their patients.
iTraceTM is a ray-tracing technology used to understand patient’s vision. iTraceTM performs both wavefront aberrometry and corneal topography with a simple, quick set of scans. iTraceTM with patented ray-tracing technology can truly separate the visual function of a patient’s cornea from their internal optics.

Implantable eye telescope End-stage macular degeneration iTrack microcatheter Age related macular Degeneration Loss of central vision CentraSight  AMD Retinal implants Improves vision iTrack Nova Eye Medical  MIGS  ab-interno canaloplasty. open-angle glaucoma ABIC Scheimpflug topographer MS39 Ray-tracing Schwind Eye tech solutions